A devastating case of misdiagnosis and delayed treatment has highlighted the critical need for accurate and timely diagnosis in women’s healthcare. Sarah Roch, a 43-year-old mother of two from Plymouth, was diagnosed with late-stage cervical cancer after a series of missed opportunities by Derriford Hospital.
Sarah’s journey began in 2010 when she received her first abnormal smear test results. Despite subsequent abnormal test results in 2011, 2012, and 2013, Sarah’s symptoms were repeatedly dismissed by healthcare providers who attributed them to constipation. It wasn’t until she insisted on a voluntary hysterectomy in 2019 that Sarah was diagnosed with late-stage cervical cancer.
The devastating diagnosis came as a shock to Sarah, who had been experiencing symptoms such as bloating, indigestion, and bleeding after sexual intercourse for years. Her symptoms had been repeatedly dismissed by healthcare providers, who failed to identify the warning signs of cervical cancer.
Sarah’s case is a stark reminder of the importance of accurate diagnosis and timely treatment in women’s healthcare. According to the NHS, more than 3,000 new cases of cervical cancer are diagnosed each year, and around 850 women die from the disease annually. The disease is often preventable, and regular screening tests can detect abnormal cells before they become cancerous.
Sarah’s story is not an isolated incident. According to Enable Law, the firm that represented Sarah in her negligence claim, the trust failed to identify biopsies taken in 2013 in a “critical error.” This failure to diagnose and treat Sarah’s cervical cancer resulted in her developing late-stage cancer, which has significantly reduced her life expectancy.
The University Hospitals Plymouth NHS Trust has admitted liability in its failure to interpret Sarah’s 2013 cervical biopsy results and has settled with her. The trust has also implemented improvements to ensure accurate reporting and interpretation of results, regular education sessions for professionals, and a requirement for additional examination of cervical screens.
Sarah’s case highlights the critical need for patient advocacy and awareness of cervical cancer symptoms. Sarah is now undergoing chemotherapy every two weeks and is calling for greater awareness of cervical cancer symptoms. She urges women to trust their instincts and seek medical attention if they experience unexplained vaginal bleeding, leaking, or discharge, or pain and discomfort in their stomach, womb, or pelvis.
Sarah’s story is a powerful reminder of the importance of accurate diagnosis, timely treatment, and patient advocacy in women’s healthcare. It is essential that healthcare providers prioritize patient safety and take steps to prevent similar cases from happening in the future.
As Sarah’s specialist clinical negligence solicitor, Ceri-Ann Taylor, has said, “Sarah’s case underscores the critical need for accurate and timely diagnosis in women’s healthcare. There were multiple missed opportunities by the NHS. If Sarah’s pre-cancerous cells had been recognised and treated, she would not have gone on to develop cervical cancer at all, and would have a normal life expectancy. Instead, her life will be cut very short, and she will leave behind her much-loved family.”
Sarah’s story is a tragic reminder of the devastating consequences of misdiagnosis and delayed treatment. It is essential that we learn from her case and work towards creating a healthcare system that prioritizes patient safety and well-being.
The Importance of Cervical Cancer Screening
Cervical cancer is a preventable disease, and regular screening tests can detect abnormal cells before they become cancerous. The NHS Cervical Screening Programme offers free smear tests to women aged 25-49, and women aged 50-64 are invited for screening every 3-5 years. Women aged 65 and over are no longer invited for screening, but can still attend for a test if they wish.
However, despite the importance of cervical cancer screening, uptake rates have been declining in recent years. According to an NHS report, uptake rates dropped to a record low of 68% in March 2023, against a target of 80% among eligible women. Figures for October to December 2023 suggest the average uptake increased to 70%, but in some areas, uptake dropped to as low as 55%.
The Impact of Misdiagnosis and Delayed Treatment
Sarah’s case highlights the devastating impact of misdiagnosis and delayed treatment on patients and their families. The consequences of delayed treatment can be severe, including reduced life expectancy, increased risk of complications, and emotional distress.
As Sarah’s specialist clinical negligence solicitor, Ceri-Ann Taylor, has said, “Sarah’s case underscores the critical need for accurate and timely diagnosis in women’s healthcare. There were multiple missed opportunities by the NHS. If Sarah’s pre-cancerous cells had been recognised and treated, she would not have gone on to develop cervical cancer at all, and would have a normal life expectancy. Instead, her life will be cut very short, and she will leave behind her much-loved family.”
Conclusion
Sarah’s story is a powerful reminder of the importance of accurate diagnosis, timely treatment, and patient advocacy in women’s healthcare. It is essential that healthcare providers prioritize patient safety and take steps to prevent similar cases from happening in the future.
As Sarah herself has said, she wants women to be aware of their bodies and to trust their instincts. If women experience unexplained vaginal bleeding, leaking, or discharge, or pain and discomfort in their stomach, womb, or pelvis, they should seek medical attention and not hesitate to seek a second opinion if they feel something is not right.
Sarah’s story is a tragic reminder of the devastating consequences of misdiagnosis and delayed treatment. It is essential that we learn from her case and work towards creating a healthcare system that prioritizes patient safety and well-being.